As of Aug 18
| +0.20 / +1.99%|
The 5 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 19.00, with a high estimate of 30.00 and a low estimate of 11.00. The median estimate represents a +85.37% increase from the last price of 10.25.
The current consensus among 5 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.